Our Process Ensures Predictable Outcomes
A multi-step process ensures we learn all we can about your needs and provide consistent, high-quality product.
Discovery and Requirements
8-12 step process.
It is vital to take the time and effort required to completely capture the knowledge you have about your product and therapeutic area. Asking the right questions at this stage is critical for helping to prevent needless expenditures and inefficiencies.
When we perform claims analysis there are many different databases from which to collect claims data. By asking our clients detailed questions about the purpose of the analysis and their knowledge of where the procedures are performed and by whom, we can propose the most appropriate resources.
Planning (GAP Analysis)
11-18 step process
For a recent cellular therapy client, performing a gap analysis was critical in their initial fundraising. By identifying exactly what additional information was needed to obtain an IND, they presented successfully to investors.
Reimbursement is its own strategic morass. By creating an overall portfolio clinical development plan, we can anticipate any resistance that may be brought by medical societies or payers. For a client in a very competitive space with huge existing competition, this enabled us to plan a sequential new coding strategy to minimize resistance.
Implementation & Execution (Clinical Development Plan)
9 step process
A carefully laid plan leads to a systematic execution and the ability to adapt when regulatory bodies change their minds. Our internal processes ensure that execution is both accurate and timely.
9-18 step process
Delivery is another dialogue. We typically deliver a draft to ensure that we are capturing everything in the statement of work. Once all parties agree on the draft final versions are produced.
“TAMM Net has been a valuable partner helping us navigate reimbursement and regulatory. They coordinated our activities with CMS including a successful C-code application and connected us with policy representatives in medical societies. TAMM Net’s regulatory team efficiently wrote and submitted our successful 510(k) application for CivaSheet. They have helped our company meet key milestones. We continue to work with TAMM Net because of the professionalism and effectiveness they bring to each task.”
Close & Continuation
6-8 step process
We engage with our clients early in the development process and stay connected after any project is done. For most of our clients, our engagement is an ongoing partnership. We want to make sure that if there are any questions about our work, we are there to answer them as they arise. Of course, this also leads to many referrals, for which we are grateful.
Just ask our clients
We customize solutions that fit the needs of needs of all our clients, and strive to ensure the success of each and every one of them
TAMM Net played a critical role in the creation of our Quality Management System. They did so in a precise and efficient manner, allowing us to meet an objective at a reasonable price. We considered a number of different firms to help us, both big and small, but we found that TAMM Net simply provided the greatest value. We are a better company because of our relationship with TAMM Net.
Art is one of the most creative people I have ever met or worked with. The integrity and intelligence he has displayed during our professional and personal relationship is remarkable. His ability to provide solid and complete analysis of the medical field is invaluable. I would recommend TAMM Net for any business consultation due to their honest and detailed commitment to excellence! Top qualities: Expert, High Integrity, Creative.
TAMM Net team brought exceptional insight and clarity to an extremely diverse and complicated landscape, adding tremendous value. December 1, 2010 Top qualities: Expert, Good Value, High Integrity
TAMM Net provided expertise in the grant development and budgeting processes enabling Atlanta Catheter Therapies, Inc. (ACT) to receive a $244,479 grant on our first application. TAMM Nets knowledge of the agency and procedures provided ACT with clear directions to facilitate completing the request. Not only do I highly recommend TAMM Net for obtaining non-dilutive research funding, but we plan to engage TAMM Net again for larger funding opportunities.
TAMM Net has been an integral and vital partner in our efforts to conduct clinical trials, obtain FDA clearances, and understand reimbursement for interventional pain management. They interacted with FDA to gain direction for clinical trial, gain approval for an IDE in 30 days. Additionally, they authored and submitted a successful 510 (K). TAMM recruited key opinion leaders to serve as principal investigators on pivotal trials, for which they wrote the protocols, in the military and private settings. They successfully negotiated very reasonable fees with the Henry Jackson Foundation and Brentwood Biomedical Institute. They help us refine our training agenda and identified quality cadaver labs. Then, they helped staff and manage those training sessions. I am pleased to recommend TAMM Net without reservations for any of these services. They bring top-notch capabilities and integrity to each project, which is why they continue to be a valuable partner after five years.
Reimbursement & Regulatory
TAMM Net has been a valuable partner helping us navigate reimbursement and regulatory. They coordinated our activities with CMS including a successful C-code application and connected us with policy representatives in medical societies. TAMM Net’s regulatory team efficiently wrote and submitted our successful 510(k) application for CivaSheet. They have helped our company meet key milestones. We continue to work with TAMM Net because of the professionalism and effectiveness they bring to each task.
TAMM Net is led by a world-class team of experienced biomedical professionals
Arthur F. Spalding
F. Blix Winston, MPA, MS
Director, Regulatory Affairs
Janan VanOsdell, MBA, MHSA
Director, Clinical Research
Dr. Darrell R. Galloway
Jennifer Short, RN
Regional Director, Clinical Research
Director of IT